AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 135 filers reported holding AMYLYX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,807,861 | -42.2% | 535,656 | -31.9% | 0.15% | -49.7% |
| Q2 2023 | $16,969,119 | +27.1% | 786,700 | +72.9% | 0.30% | +16.3% |
| Q1 2023 | $13,349,700 | +30.7% | 455,000 | +25.4% | 0.26% | +83.0% |
| Q3 2022 | $10,213,000 | +78.4% | 362,847 | +22.1% | 0.14% | +80.8% |
| Q2 2022 | $5,725,000 | +199.4% | 297,251 | +99.8% | 0.08% | +239.1% |
| Q1 2022 | $1,912,000 | – | 148,767 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,088,333 | $224,963,904 | 6.32% |
| Alpha Wave Global, LP | 821,220 | $30,344,079 | 5.54% |
| Ghost Tree Capital, LLC | 350,000 | $12,933,000 | 5.52% |
| Boxer Capital, LLC | 2,084,000 | $77,003,800 | 4.06% |
| Altium Capital Management LP | 140,000 | $5,173,000 | 2.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,693,000 | $99,506,350 | 2.06% |
| Iron Triangle Partners LP | 240,240 | $8,876,868 | 1.59% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 655,015 | $24,202,804 | 1.50% |
| EMERALD ADVISERS, LLC | 836,909 | $30,923,788 | 1.49% |
| GREAT POINT PARTNERS LLC | 190,000 | $7,020,500 | 1.38% |